These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19619339)

  • 1. Carbonic anhydrase 9 is a predictive marker of survival benefit from lower dose of bevacizumab in patients with previously treated metastatic colorectal cancer.
    Hong YS; Cho HJ; Kim SY; Jung KH; Park JW; Choi HS; Oh JH; Kim BC; Sohn DK; Kim DY; Chang HJ
    BMC Cancer; 2009 Jul; 9():246. PubMed ID: 19619339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expressions of carbonic anhydrase 9 and vascular endothelial growth factor in astrocytic tumors predict a poor prognosis.
    Yoo H; Sohn S; Nam BH; Min HS; Jung E; Shin SH; Gwak HS; Lee SH
    Int J Mol Med; 2010 Jul; 26(1):3-9. PubMed ID: 20514415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-expression of VEGF and CA9 in ovarian high-grade serous carcinoma and relationship to survival.
    Williams E; Martin S; Moss R; Durrant L; Deen S
    Virchows Arch; 2012 Jul; 461(1):33-9. PubMed ID: 22699808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of serum CA9 in patients with metastatic clear cell renal cell carcinoma under targeted therapy.
    Gigante M; Li G; Ferlay C; Perol D; Blanc E; Paul S; Zhao A; Tostain J; Escudier B; Negrier S; Genin C
    Anticancer Res; 2012 Dec; 32(12):5447-51. PubMed ID: 23225450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase 9 is associated with chemosensitivity and prognosis in breast cancer patients treated with taxane and anthracycline.
    Aomatsu N; Yashiro M; Kashiwagi S; Kawajiri H; Takashima T; Ohsawa M; Wakasa K; Hirakawa K
    BMC Cancer; 2014 Jun; 14():400. PubMed ID: 24893880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas.
    Yoo H; Baia GS; Smith JS; McDermott MW; Bollen AW; Vandenberg SR; Lamborn KR; Lal A
    Clin Cancer Res; 2007 Jan; 13(1):68-75. PubMed ID: 17200340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated carbonic anhydrases are linked to metastases in primary cervical cancer.
    Kim JY; Shin HJ; Kim TH; Cho KH; Shin KH; Kim BK; Roh JW; Lee S; Park SY; Hwang YJ; Han IO
    J Cancer Res Clin Oncol; 2006 May; 132(5):302-8. PubMed ID: 16416108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased peritherapeutic VEGF expression could be a predictor of responsiveness to first-line FOLFIRI plus bevacizumab in mCRC patients.
    Tsai HL; Lin CH; Huang CW; Yang IP; Yeh YS; Hsu WH; Wu JY; Kuo CH; Tseng FY; Wang JY
    Int J Clin Exp Pathol; 2015; 8(2):1900-10. PubMed ID: 25973082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma.
    Hoogsteen IJ; Marres HA; Wijffels KI; Rijken PF; Peters JP; van den Hoogen FJ; Oosterwijk E; van der Kogel AJ; Kaanders JH
    Clin Cancer Res; 2005 Jan; 11(1):97-106. PubMed ID: 15671533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
    Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
    Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors.
    Cetin B; Gonul II; Buyukberber S; Afsar B; Gumusay O; Algın E; Turan N; Ozet A; Benekli M; Coskun U
    Tumour Biol; 2015 Nov; 36(11):8471-8. PubMed ID: 26026587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas.
    Driessen A; Landuyt W; Pastorekova S; Moons J; Goethals L; Haustermans K; Nafteux P; Penninckx F; Geboes K; Lerut T; Ectors N
    Ann Surg; 2006 Mar; 243(3):334-40. PubMed ID: 16495697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer.
    Boisen MK; Johansen JS; Dehlendorff C; Larsen JS; Østerlind K; Hansen J; Nielsen SE; Pfeiffer P; Tarpgaard LS; Holländer NH; Keldsen N; Hansen TF; Jensen BB; Jensen BV
    Ann Oncol; 2013 Oct; 24(10):2554-2559. PubMed ID: 23864097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of carbonic anhydrase 9 is a novel prognostic marker in resectable hepatocellular carcinoma.
    Kang HJ; Kim IH; Sung CO; Shim JH; Yu E
    Virchows Arch; 2015 Apr; 466(4):403-13. PubMed ID: 25577552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy.
    Pohl A; El-Khoueiry A; Yang D; Zhang W; Lurje G; Ning Y; Winder T; Hu-Lieskoven S; Iqbal S; Danenberg KD; Kahn M; Teo JL; Shriki J; Stebbing J; Lenz HJ
    Pharmacogenomics J; 2013 Apr; 13(2):173-80. PubMed ID: 22231565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of carbonic anhydrase IX is associated with postoperative recurrence and poor prognosis in surgically treated oral squamous cell carcinoma.
    Choi SW; Kim JY; Park JY; Cha IH; Kim J; Lee S
    Hum Pathol; 2008 Sep; 39(9):1317-22. PubMed ID: 18440050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic anhydrase IX is associated with early pulmonary spreading of primary colorectal carcinoma and tobacco smoking.
    Schweiger T; Kollmann D; Nikolowsky C; Traxler D; Guenova E; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
    Eur J Cardiothorac Surg; 2014 Jul; 46(1):92-9. PubMed ID: 24321995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase IX as a marker for poor prognosis in soft tissue sarcoma.
    Måseide K; Kandel RA; Bell RS; Catton CN; O'Sullivan B; Wunder JS; Pintilie M; Hedley D; Hill RP
    Clin Cancer Res; 2004 Jul; 10(13):4464-71. PubMed ID: 15240538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of anti-angiogenic therapy in metastatic colorectal cancer (mCRC): original data and review of the literature.
    Pohl M; Werner N; Munding J; Tannapfel A; Graeven U; Nickenig G; Schmiegel W; Reinacher-Schick A
    Z Gastroenterol; 2011 Oct; 49(10):1398-406. PubMed ID: 21964893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy.
    McIntyre A; Patiar S; Wigfield S; Li JL; Ledaki I; Turley H; Leek R; Snell C; Gatter K; Sly WS; Vaughan-Jones RD; Swietach P; Harris AL
    Clin Cancer Res; 2012 Jun; 18(11):3100-11. PubMed ID: 22498007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.